LAVA Therapeutics NV LVTX 深 沪
等待开盘 07-30 09:30:00 美东时间
1.47
-0.050
-3.29%
华盛通- 最 高1.56
- 今 开1.50
- 成交量 5.20万股
- 最 低 1.4555
- 昨 收 1.52
- 总市值 3866.88万
- 52周最高 2.093
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.8502
- 委 比 27.99%
- 总股本 2630.53万
- 历史最高 17.20
- 量 比 0.80
- 振 幅 6.88%
- 历史最低 0.8502
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JMP Securities Reiterates Market Perform on LAVA Therapeuticsto Market Perform
JMP Securities analyst Reni Benjamin reiterates LAVA Therapeutics (NASDAQ:LVTX) from Market Perform to Market Perform.
05-15 22:08
LAVA Therapeutics Q1 EPS $(0.13) Beats $(0.38) Estimate
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.38) by 65.79 percent. This is a 550 percent decrease over losses of $(0.02) per share from
05-14 19:40
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
LAVA Therapeutics reviews strategic options amid cost cuts. HC Wainwright downgrades stock, citing uncertainties over LAVA-1266 and possible business shifts.
03-01 01:32
美股大行评级 | Susquehanna：维持AerCap Holdings"积极"评级，目标价从108美元升至120美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102154574572916737.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Prothena Corp(PRTA)"超配"评级，目标价从94美元升至110美元</p> <p>• Stifel：维持GH Research(GHRS)"买入"评级，目标价从18美元升至3
02-28 09:50
Lava Therapeutics shares are trading higher after the company announced the evaluation of strategic options.
Lava Therapeutics shares are trading higher after the company announced the eva...
02-25 21:43
LAVA Therapeutics Announces Restructuring Plan for 2025
LAVA Therapeutics ( ($LVTX) ) has issued an announcement. On February 20, 2025,...
02-25 20:29
LAVA Therapeutics to Transition to U.S. Domestic Issuer
The latest update is out from LAVA Therapeutics ( ($LVTX) ). LAVA Therapeutics ...
01-02 22:18
美股大行评级 | 潜在升幅233%，SenesTech目标价获上调至10美元
<span> <meta content="no-referrer" name="referrer"></span><img src="https://r.hstong.com/public/cms/images/2024/12/13/20241213084359656.png" referrerpolicy="no-referrer"><figure class="table" style="overflow-x: scroll;"> <table> <tbody> <tr> <td>标的</td> <td>代码</td> <td>评级</td> <td>目标价</td> <td>当前价</td> <td>潜在涨跌幅</td> <td>机构名称</td> </tr> <tr> <td>SenesTech</td> <td>SNES</td> <td>上调</td> <t
2024-12-13 08:44
快讯 | LAVA Therapeutics NV : Leerink Partners 将评级从"优于大盘"下调至"市场表现"
LAVA Therapeutics NV : Leerink Partners Cuts to Market Perform From Outperform
2024-12-12 19:04
